Celtaxsys

PharmaceuticalsSeries EAtlanta, USceltaxsys.com

Latest round

Series E

Last raised

Dec 2017

Total raised

$22M

Investors

6

About Celtaxsys

Founded in 2007 and based in Georgia, US, Celtaxsys, Inc. is a pharmaceutical development company focused on novel therapeutics that treat inflammatory disease through regulation of immune cell migration and activation.

Who invested in Celtaxsys

6 investors across 2 rounds

See all investors in Celtaxsys

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Dec 18, 2017

    Amount

    Undisclosed

    Investors

    Locked

  2. Series D

    Jun 8, 2015

    Amount

    $22M

    Investors

    Locked

Questions about Celtaxsys

Who invested in Celtaxsys?

Celtaxsys has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Celtaxsys raised?

Celtaxsys has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Celtaxsys last raise money?

Celtaxsys's most recent round on record is a Series E, in Dec 2017.

What does Celtaxsys do?

Founded in 2007 and based in Georgia, US, Celtaxsys, Inc.

Where is Celtaxsys headquartered?

Celtaxsys is headquartered in Atlanta, US.

Which VCs invest in companies like Celtaxsys?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Celtaxsys's stage. Their profiles are linked below.

Raising like Celtaxsys? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.